Medicinal chemistry, process R&D, pharmaceutical impurities and custom synthesis — built on documentation-first discipline and a genuine partner mindset from milligram to multi-gram scale.
From early discovery through regulatory submission — structured, documented, and designed to move fast without cutting corners.
Analog design, SAR support, and rapid synthesis iteration. We integrate as an extension of your discovery team — fully documented, fast-responding, and ready to pivot at any stage of your lead optimisation campaign.
Route scouting, process optimisation, impurity profiling, and scale-up readiness with risk-managed alternates and full documentation.
DetailsFTE or fee-for-service models. NDA-first approach. Milligram to multi-gram quantities with CoA and full analytical package included.
Engagement modelsReference standard synthesis, impurity isolation, and full characterisation for IND/NDA submissions. ICH Q3A/Q3B compliant with traceable analytical data.
Four structured stages that keep you informed, audit-ready, and in full control — from intake through final delivery.
CRO discipline with in-house flexibility. We take ownership of your program — not just orders.
Share your requirement — we'll reply with next steps, realistic timelines, and a practical synthesis plan. No commitment needed for an initial discussion.